Drug Discovery Looks for Its Next Fix

By Michael Feldman

July 31, 2012

Despite the highly profitable nature of the pharmaceutical business and the large amount of R&D money companies throw at creating new medicines, the pace of drug development is agonizingly slow.  Over the last few years, on average, less than two dozen new drugs have been introduced per year. One of the more promising technologies that could help speed up this process is supercomputing, which can be used not only to find better, safer drugs, but also to weed out those compounds that would eventually fail during the latter stages of drug trials.

According to a 2010 report in Nature, big pharma spends something like $50 billion per year on drug research and development. (To put that in perspective, that’s four to five times the total spend for high performance computing.) The Nature report estimates the price tag to bring a drug successfully to market is about $1.8 billion, and rising. A lot of that cost is due to the high attrition rate of drugs, which is caused by problems in absorption, distribution, metabolism, excretion and toxicity that gets uncovered during clinical trials.

Ideally, the drug makers would like know which compounds were going to succeed before they got to the expensive stages of development. That’s where high performance computing can help. The approach is to use molecular docking simulations on the computer to determine if the drug candidate can bind to the target protein associated with the disease. The general idea is to find the key (the small molecule drug) that fits in the lock (the protein).

AutoDock, probably the most common molecular modeling application for protein docking, is a one of the more popular software package used by the drug research community. It played a role in developing some of the more successful HIV drugs on the market. Fortunately, AutoDock is freely available under the GNU General Public License.

The trick is to do these docking simulations on a grand scale. Thanks to the power of modern HPC machines, millions of compounds can now be screened against a protein in a reasonable amount of time. In truth, that timeframe is dependent upon how many cores you can put to the task. For a typical medium-sized cluster that a drug company might have in-house, it would take several weeks to screen just a few thousand compounds against one target protein. To reach a more interactive workflow, you need a something approaching a petascale supercomputer.

But not necessarily an actual supercomputer. Compute clouds have turned out to be very suitable for this type of embarrassing parallel application. For example, in a recent test with 50,000 cores on Amazon’s cloud (provisioned by Cycle Computing), software was able to screen 21 million compounds against a protein target in less than three hours.

Real supercomputers work too. At Oak Ridge National Lab (ORNL), researchers there used 50,000 cores of Jaguar to screen about 10 million drug candidates in less than a day. Jeremy C. Smith, director of the Center for Molecular Biophysics at ORNL, believes his type level of virtual screening is the most cost-effective approach to turbo-charge the drug pipeline. But the real utility of the supercomputing approach, says Smith, is that it can also be used to screen out drugs with toxic side effects.

Toxicity is often hard to detect until it comes time to do clinical trials, the most expensive and time-consuming phase of drug development. Worse yet, sometimes toxicity is not discovered until after the drug has been approved and released into the wild. So identifying these compounds early has the potential to save lots of money, not to mention lives. As Smith says, “If drug candidates are going to fail, you want them to fail fast, fail cheap.”

At the molecular level, toxicity is caused by a drug binding to the wrong protein, one that is actually needed by the body, rather than just selectively binding to the protein causing the condition. The problem is humans have about a thousand proteins, so every potential compound needs to be checked against each one. When you’re working with millions of drug candidates, the job becomes overwhelming, even for the petaflop supercomputers of today. To support the toxicity problem, you’ll need an exascale machine, says Smith.

Besides screening for toxicity, the same exascale setup can be used to repurpose existing drugs for other medical conditions. That is, the drug docking software could use approved drugs as the starting point and try to match them against various target proteins know to cause disease. Right now, drug repurposing is typically discovered on a trial-and-error basis, but the increasing number of compounds that are now in this multiple-use category suggests this could be rich new area of drug discovery.

In any case, sheer compute power is not the complete answer. For starters, the software has to be scaled up to the level of the hardware, and on an exascale machine, that hardware is more than likely going to be based on heterogenous processors. But since the problem is easily parallelized (each docking operation can be performed independently of one another), at least the scaling aspect should be relatively easy to overcome.

The larger problem is that the molecular modeling software itself is imperfect. Unlike a true lock and key, proteins are dynamic structures, and the action of binding to a molecule changes their shape. Therefore, physics simulation is also required to get a more precise match.

AutoDock, for example, is only able to provide a crude match between drug and protein. To get higher fidelity docking, more compute-intensive algorithms are required. Researchers, like those at ORNL, often resort to more precise molecular dynamics codes after getting performing a crude screening run with AutoDock.

None of this is a guarantee that virtual docking on exascale machines is going to launch a golden age of drugs. It’s possible that researchers will discover that there are just a handful of small molecule compounds that actually exhibit both disease efficacy and are non-toxic. But Smith believes this approach is full of promise. “This is the way to design drugs since this mirrors the way nature works,” he says.

Subscribe to HPCwire's Weekly Update!

Be the most informed person in the room! Stay ahead of the tech trends with industy updates delivered to you every week!

Nvidia Shuts Out RISC-V Software Support for GPUs 

September 23, 2022

Nvidia is not interested in bringing software support to its GPUs for the RISC-V architecture despite being an early adopter of the open-source technology in its GPU controllers. Nvidia has no plans to add RISC-V support for CUDA, which is the proprietary GPU software platform, a company representative... Read more…

Microsoft Closes Confidential Computing Loop with AMD’s Milan Chip

September 22, 2022

Microsoft shared details on how it uses an AMD technology to secure artificial intelligence as it builds out a secure AI infrastructure in its Azure cloud service. Microsoft has a strong relationship with Nvidia, but is also working with AMD's Epyc chips (including the new 3D VCache series), MI Instinct accelerators, and also... Read more…

Nvidia Introduces New Ada Lovelace GPU Architecture, OVX Systems, Omniverse Cloud

September 20, 2022

In his GTC keynote today, Nvidia CEO Jensen Huang launched another new Nvidia GPU architecture: Ada Lovelace, named for the legendary mathematician regarded as the first computer programmer. The company also announced tw Read more…

Nvidia’s Hopper GPUs Enter ‘Full Production,’ DGXs Delayed Until Q1

September 20, 2022

Just about six months ago, Nvidia’s spring GTC event saw the announcement of its hotly anticipated Hopper GPU architecture. Now, the GPU giant is announcing that Hopper-generation GPUs (which promise greater energy eff Read more…

NeMo LLM Service: Nvidia’s First Cloud Service Makes AI Less Vague

September 20, 2022

Nvidia is trying to uncomplicate AI with a cloud service that makes AI and its many forms of computing less vague and more conversational. The NeMo LLM service, which Nvidia called its first cloud service, adds a layer of intelligence and interactivity... Read more…

AWS Solution Channel

Shutterstock 1194728515

Simulating 44-Qubit quantum circuits using AWS ParallelCluster

Dr. Fabio Baruffa, Sr. HPC & QC Solutions Architect
Dr. Pavel Lougovski, Pr. QC Research Scientist
Tyson Jones, Doctoral researcher, University of Oxford

Introduction

Currently, an enormous effort is underway to develop quantum computing hardware capable of scaling to hundreds, thousands, and even millions of physical (non-error-corrected) qubits. Read more…

Microsoft/NVIDIA Solution Channel

Shutterstock 1166887495

Improving Insurance Fraud Detection using AI Running on Cloud-based GPU-Accelerated Systems

Insurance is a highly regulated industry that is evolving as the industry faces changing customer expectations, massive amounts of data, and increased regulations. A major issue facing the industry is tracking insurance fraud. Read more…

Nvidia Targets Computers for Robots in the Surgery Rooms

September 20, 2022

Nvidia is laying the groundwork for a future in which humans and robots will be collaborators in the surgery rooms at hospitals. The company announced a computer called IGX for Medical Devices, which will be populated in robots, image scanners and other computers and medical devices involved in patient care close to the point... Read more…

Nvidia Shuts Out RISC-V Software Support for GPUs 

September 23, 2022

Nvidia is not interested in bringing software support to its GPUs for the RISC-V architecture despite being an early adopter of the open-source technology in its GPU controllers. Nvidia has no plans to add RISC-V support for CUDA, which is the proprietary GPU software platform, a company representative... Read more…

Nvidia Introduces New Ada Lovelace GPU Architecture, OVX Systems, Omniverse Cloud

September 20, 2022

In his GTC keynote today, Nvidia CEO Jensen Huang launched another new Nvidia GPU architecture: Ada Lovelace, named for the legendary mathematician regarded as Read more…

Nvidia’s Hopper GPUs Enter ‘Full Production,’ DGXs Delayed Until Q1

September 20, 2022

Just about six months ago, Nvidia’s spring GTC event saw the announcement of its hotly anticipated Hopper GPU architecture. Now, the GPU giant is announcing t Read more…

NeMo LLM Service: Nvidia’s First Cloud Service Makes AI Less Vague

September 20, 2022

Nvidia is trying to uncomplicate AI with a cloud service that makes AI and its many forms of computing less vague and more conversational. The NeMo LLM service, which Nvidia called its first cloud service, adds a layer of intelligence and interactivity... Read more…

Nvidia Targets Computers for Robots in the Surgery Rooms

September 20, 2022

Nvidia is laying the groundwork for a future in which humans and robots will be collaborators in the surgery rooms at hospitals. The company announced a computer called IGX for Medical Devices, which will be populated in robots, image scanners and other computers and medical devices involved in patient care close to the point... Read more…

Survey Results: PsiQuantum, ORNL, and D-Wave Tackle Benchmarking, Networking, and More

September 19, 2022

The are many issues in quantum computing today – among the more pressing are benchmarking, networking and development of hybrid classical-quantum approaches. Read more…

HPC + AI Wall Street to Feature ‘Spooky’ Science for Financial Services

September 18, 2022

Albert Einstein famously described quantum mechanics as "spooky action at a distance" due to the non-intuitive nature of superposition and quantum entangled par Read more…

Analog Chips Find a New Lease of Life in Artificial Intelligence

September 17, 2022

The need for speed is a hot topic among participants at this week’s AI Hardware Summit – larger AI language models, faster chips and more bandwidth for AI machines to make accurate predictions. But some hardware startups are taking a throwback approach for AI computing to counter the more-is-better... Read more…

AWS Takes the Short and Long View of Quantum Computing

August 30, 2022

It is perhaps not surprising that the big cloud providers – a poor term really – have jumped into quantum computing. Amazon, Microsoft Azure, Google, and th Read more…

The Final Frontier: US Has Its First Exascale Supercomputer

May 30, 2022

In April 2018, the U.S. Department of Energy announced plans to procure a trio of exascale supercomputers at a total cost of up to $1.8 billion dollars. Over the ensuing four years, many announcements were made, many deadlines were missed, and a pandemic threw the world into disarray. Now, at long last, HPE and Oak Ridge National Laboratory (ORNL) have announced that the first of those... Read more…

US Senate Passes CHIPS Act Temperature Check, but Challenges Linger

July 19, 2022

The U.S. Senate on Tuesday passed a major hurdle that will open up close to $52 billion in grants for the semiconductor industry to boost manufacturing, supply chain and research and development. U.S. senators voted 64-34 in favor of advancing the CHIPS Act, which sets the stage for the final consideration... Read more…

Top500: Exascale Is Officially Here with Debut of Frontier

May 30, 2022

The 59th installment of the Top500 list, issued today from ISC 2022 in Hamburg, Germany, officially marks a new era in supercomputing with the debut of the first-ever exascale system on the list. Frontier, deployed at the Department of Energy’s Oak Ridge National Laboratory, achieved 1.102 exaflops in its fastest High Performance Linpack run, which was completed... Read more…

Chinese Startup Biren Details BR100 GPU

August 22, 2022

Amid the high-performance GPU turf tussle between AMD and Nvidia (and soon, Intel), a new, China-based player is emerging: Biren Technology, founded in 2019 and headquartered in Shanghai. At Hot Chips 34, Biren co-founder and president Lingjie Xu and Biren CTO Mike Hong took the (virtual) stage to detail the company’s inaugural product: the Biren BR100 general-purpose GPU (GPGPU). “It is my honor to present... Read more…

Newly-Observed Higgs Mode Holds Promise in Quantum Computing

June 8, 2022

The first-ever appearance of a previously undetectable quantum excitation known as the axial Higgs mode – exciting in its own right – also holds promise for developing and manipulating higher temperature quantum materials... Read more…

AMD’s MI300 APUs to Power Exascale El Capitan Supercomputer

June 21, 2022

Additional details of the architecture of the exascale El Capitan supercomputer were disclosed today by Lawrence Livermore National Laboratory’s (LLNL) Terri Read more…

Tesla Bulks Up Its GPU-Powered AI Super – Is Dojo Next?

August 16, 2022

Tesla has revealed that its biggest in-house AI supercomputer – which we wrote about last year – now has a total of 7,360 A100 GPUs, a nearly 28 percent uplift from its previous total of 5,760 GPUs. That’s enough GPU oomph for a top seven spot on the Top500, although the tech company best known for its electric vehicles has not publicly benchmarked the system. If it had, it would... Read more…

Leading Solution Providers

Contributors

Exclusive Inside Look at First US Exascale Supercomputer

July 1, 2022

HPCwire takes you inside the Frontier datacenter at DOE's Oak Ridge National Laboratory (ORNL) in Oak Ridge, Tenn., for an interview with Frontier Project Direc Read more…

AMD Opens Up Chip Design to the Outside for Custom Future

June 15, 2022

AMD is getting personal with chips as it sets sail to make products more to the liking of its customers. The chipmaker detailed a modular chip future in which customers can mix and match non-AMD processors in a custom chip package. "We are focused on making it easier to implement chips with more flexibility," said Mark Papermaster, chief technology officer at AMD during the analyst day meeting late last week. Read more…

Intel Reiterates Plans to Merge CPU, GPU High-performance Chip Roadmaps

May 31, 2022

Intel reiterated it is well on its way to merging its roadmap of high-performance CPUs and GPUs as it shifts over to newer manufacturing processes and packaging technologies in the coming years. The company is merging the CPU and GPU lineups into a chip (codenamed Falcon Shores) which Intel has dubbed an XPU. Falcon Shores... Read more…

Nvidia Shuts Out RISC-V Software Support for GPUs 

September 23, 2022

Nvidia is not interested in bringing software support to its GPUs for the RISC-V architecture despite being an early adopter of the open-source technology in its GPU controllers. Nvidia has no plans to add RISC-V support for CUDA, which is the proprietary GPU software platform, a company representative... Read more…

Nvidia, Intel to Power Atos-Built MareNostrum 5 Supercomputer

June 16, 2022

The long-troubled, hotly anticipated MareNostrum 5 supercomputer finally has a vendor: Atos, which will be supplying a system that includes both Nvidia and Inte Read more…

UCIe Consortium Incorporates, Nvidia and Alibaba Round Out Board

August 2, 2022

The Universal Chiplet Interconnect Express (UCIe) consortium is moving ahead with its effort to standardize a universal interconnect at the package level. The c Read more…

Using Exascale Supercomputers to Make Clean Fusion Energy Possible

September 2, 2022

Fusion, the nuclear reaction that powers the Sun and the stars, has incredible potential as a source of safe, carbon-free and essentially limitless energy. But Read more…

Is Time Running Out for Compromise on America COMPETES/USICA Act?

June 22, 2022

You may recall that efforts proposed in 2020 to remake the National Science Foundation (Endless Frontier Act) have since expanded and morphed into two gigantic bills, the America COMPETES Act in the U.S. House of Representatives and the U.S. Innovation and Competition Act in the U.S. Senate. So far, efforts to reconcile the two pieces of legislation have snagged and recent reports... Read more…

  • arrow
  • Click Here for More Headlines
  • arrow
HPCwire